Sudarshan Pharma Industries Ltd. logo

Sudarshan Pharma Industries was incorporated on July 23, 2008. The company is engaged in the business of specialty chemicals and intermediates for pharma, agrochemicals, coating, paints, adhesives, etc. It is also into manufacturing active pharmaceutical ingredients.

Bidding Dates
09 Mar 2023 - 14 Mar 2023
Subscription
1.06x Oversubscribed
Minimum InvestmentMinimum LotMaximum LotLot SizeNumber of SharesIssue Price BandPost Issue Promoter Holding %Issue SizeIPO Document
₹1,16,8001116006.9 M₹71 - ₹7371.48 %₹487.2 M - ₹501.0 MRHP DOC

Sudarshan Pharma IPO SUBSCRIPTION STATUS

14 Mar '23
Total1.06x
Retail Individual Investor1.2x
HNI (NII) Investors0.81x
Qualified Institutional Buyers1.01x

Sudarshan Pharma IPO overall subscription rate was 1.06 times the total available shares

Sudarshan Pharma IPO retail subscription rate was 1.2 times in the retail segment

Sudarshan Pharma IPO non-institutional investor subscription rate was 0.81 times in the non-institutional investor category

Sudarshan Pharma IPO Qualified Institutional Bidder subscription rate was 1.01 times the available shares for Qualified Institutional Bidder

DayRetail Individual InvestorHNI (NII) InvestorsQualified Institutional Buyers
Category Reservation35%15%50%
14 Mar 2023
(Day 4)
1.2x0.81x1.01x
13 Mar 2023
(Day 3)
0.88x0.58x0x
10 Mar 2023
(Day 2)
0.67x0.38x0x
09 Mar 2023
(Day 1)
0.47x0.37x0x

Sudarshan Pharma FINANCIALS

Period Net Profit (Rs in millions) Revenue from Operations (Rs in millions) Cash Flow from Operations (Rs in millions) Free Cash Flow (Rs in millions)
H1FY23 36.1 1,954.9 84.4 -27.7
FY22 53.0 3,570.9 -37.4 -48.6
FY21 26.7 1,933.5 27.9 14.7
FY20 12.8 1,479.8 6.7 -33.7

Sudarshan Pharma IPO SUBSCRIPTION STATUS DETAILS

Sudarshan Pharma had 6.9 M shares on offer

Sudarshan Pharma IPO offer price was in the range ₹71 - ₹73

Sudarshan Pharma IPO minimum Investment was116800

Sudarshan Pharma IPO issue size was ₹ 487.2 M - ₹ 501.0 M

Sudarshan Pharma had a minimum lot size of 1600 Shares per application

Sudarshan Pharma NUMBER OF SHARES ON OFFER

Total6.9 M
Fresh Issue6.9 M
Offer for Sale0
Post Issue Promoter Holding %71.48 %

Sudarshan Pharma IPO IMPORTANT DATES

Issue Open Date09 Mar 2023
Issue close Date14 Mar 2023
Allotment Date17 Mar 2023
Refund Date20 Mar 2023
Demat Account Credit Date21 Mar 2023
Listing Date22 Mar 2023
Listing on Exchange(s)BSE
Sudarshan Pharma Allotment StatusExchange

Sudarshan Pharma IPO subscription opened on 09 Mar 2023, and closed on 14 Mar 2023

IPO allotment for Sudarshan Pharma was finalized on Friday, 17 Mar 2023

IPO listing for Sudarshan Pharma was on BSE on Wednesday, 22 Mar 2023

Sudarshan Pharma IPO LISTING GAINS

Issue Price (adjusted)7.3
Listing Open Price73.0
Listing Close Price69.3
Listing Gain%0.0%
Current Gain%365.8%

Sudarshan Pharma Peer

StockStock PriceMarket Cap (Rs crore)PE TTMPEG TTMPS TTMROE%ROA%Annual Revenue (Rs crore)Annual Revenue Growth %Annual Net Profit (Rs crore)Annual Net Profit Growth %EPS TTMEPS TTM Growth %
Sudarshan Pharma Industries Ltd.3481.835.10.81.2153.6711.840.223.346.1145.6
Pidilite Industries Ltd.1660168953.263.831122.615.91486711.12448.917.92621.4
SRF Ltd.261577515.135.90.74.613.17.615893.67.21835.246.772.951.1
Gujarat Fluorochemicals Ltd.4518.149631.385.914.79.97.34.950383.85785.852.65.9
Himadri Speciality Chemical Ltd.752.637975.847.51.67.61611.948323.6751.335.215.830
Aether Industries Ltd.1591.621122.589.82.617.38.96.81181.134.2219.538.517.734

Sudarshan Pharma INFORMATION ON IPO ISSUE

About Sudarshan Pharma

Sudarshan Pharma Industries was incorporated on July 23, 2008. The company is engaged in the business of specialty chemicals and intermediates for pharma, agrochemicals, coating, paints, adhesives, etc. It is also into manufacturing active pharmaceutical ingredients.

Object of the Issue

  1. Working capital requirements
  2. General corporate purposes

Sudarshan Pharma - PROMOTERS

Name
Hemal Vasantrai Mehta
Sachin Vasantrai Mehta

Sudarshan Pharma Lead Manager of the Issue

Gretex Corporate Services Limited

info@gretexgroup.com

Sudarshan Pharma Registrar to the issue

Kfin Technologies Private Limited

einward.ris@kfintech.com

Sudarshan Pharma Strengths

Scalable business model

The company has a scalable business model as it is customer-centric and order driven, and requires optimum utilization of the existing resources, assuring quality supply

Strength

Range of products

The company has more than 2,000 specialty chemicals and intermediates for pharma, agrochemicals, coating, paints and adhesives. It is also into manufacturing active pharmaceutical ingredients

Strength

Diversified business operations

The business is diversified in terms of geography and therapeutic areas in the pharmaceutical industry, and specialty chemicals in the chemical industry

Strength

Sudarshan Pharma Risks

Outstanding legal proceedings

There are outstanding legal proceedings involving the company, subsidiary, group entity, promoters and directors. Any adverse decision in such proceedings may have an adverse effect on the business

Risk

Highly competitive industry

The company operates in a highly competitive industry, which could limit its ability to grow

Risk

IPO FAQs

  • The promoters of the company are Hemal Vasantrai Mehta and Sachin Vasantrai Mehta.

  • The category allocation of qualified institutional buyers is 50.0%, the category allocation of non individual investors or high networth individuals is 15.0% and for retail investors it is 35.0%.

  • The price band of the IPO is Rs 71.0 - 73.0.

  • The IPO application opens on Mar 09, 2023 and closes on Mar 14, 2023.

  • The minimum lot size for the IPO is 1600. The maximum lot size for the IPO is 1600.

  • For all category investors, the minimum application amount for this IPO is Rs. 116,800.0, the maximum value for this IPO is Rs 116,800.0.

  • This IPO will be allotted on Mar 17, 2023.

  • The refund will be credited to your account on Mar 20, 2023.

  • The allotted shares will be credited to your demat on Mar 21, 2023.

  • Sudarshan Pharma Industries Ltd.’s shares listed on the stock exchanges on Mar 22, 2023.